London
· Delayed Price · Currency is GBP · Price in EUR Cellectis Statistics
Total Valuation
Cellectis has a market cap or net worth of GBP 127.48 million. The enterprise value is 75.00 million.
| Market Cap | 127.48M |
| Enterprise Value | 75.00M |
Important Dates
The next estimated earnings date is Wednesday, March 5, 2025.
| Earnings Date | Mar 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +57.15% |
| Shares Change (QoQ) | +11.40% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 71.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 1.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.19 |
| EV / Sales | 2.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.66 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.69.
| Current Ratio | 1.78 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.49 |
| Interest Coverage | -10.99 |
Financial Efficiency
Return on equity (ROE) is -82.20% and return on invested capital (ROIC) is -25.71%.
| Return on Equity (ROE) | -82.20% |
| Return on Assets (ROA) | -16.09% |
| Return on Capital (ROIC) | -25.71% |
| Revenue Per Employee | 122,790 |
| Profits Per Employee | -287,804 |
| Employee Count | 221 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.98% in the last 52 weeks. The beta is 3.20, so Cellectis's price volatility has been higher than the market average.
| Beta (5Y) | 3.20 |
| 52-Week Price Change | -36.98% |
| 50-Day Moving Average | 1.72 |
| 200-Day Moving Average | 1.98 |
| Relative Strength Index (RSI) | 39.19 |
| Average Volume (20 Days) | 451 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cellectis had revenue of GBP 26.89 million and -63.03 million in losses. Loss per share was -0.77.
| Revenue | 26.89M |
| Gross Profit | 26.34M |
| Operating Income | -58.16M |
| Pretax Income | -63.41M |
| Net Income | -63.03M |
| EBITDA | -50.15M |
| EBIT | -58.16M |
| Loss Per Share | -0.77 |
Balance Sheet
The company has 118.69 million in cash and 67.05 million in debt, giving a net cash position of 51.64 million.
| Cash & Cash Equivalents | 118.69M |
| Total Debt | 67.05M |
| Net Cash | 51.64M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 96.56M |
| Book Value Per Share | 0.96 |
| Working Capital | 96.08M |
Cash Flow
In the last 12 months, operating cash flow was 46.82 million and capital expenditures -1.72 million, giving a free cash flow of 45.10 million.
| Operating Cash Flow | 46.82M |
| Capital Expenditures | -1.72M |
| Free Cash Flow | 45.10M |
| FCF Per Share | n/a |
Margins
Gross margin is 97.96%, with operating and profit margins of -216.28% and -234.39%.
| Gross Margin | 97.96% |
| Operating Margin | -216.28% |
| Pretax Margin | -235.80% |
| Profit Margin | -234.39% |
| EBITDA Margin | -186.49% |
| EBIT Margin | -216.28% |
| FCF Margin | 167.70% |
Dividends & Yields
Cellectis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -57.15% |
| Shareholder Yield | -57.15% |
| Earnings Yield | -49.44% |
| FCF Yield | 35.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cellectis has an Altman Z-Score of -1.32. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.32 |
| Piotroski F-Score | n/a |